Latest Director Participation News

Riedel Resources Limited has announced a 1 for 2 non-renounceable entitlement offer at $0.025 per share, aiming to raise approximately $1.78 million to fund exploration and working capital. The offer closes on 15 December 2025 and is open to eligible shareholders.

Tartana Minerals has secured a $1.275 million placement priced at a 17% premium, including significant director participation pending shareholder approval. The capital raise aims to strengthen working capital and retire convertible notes, supporting advancement of its Chillagoe assets.

Krakatoa Resources has launched an offer of over 237 million new options linked to its recent $3.1 million placement, aiming to reward investors and advisors while providing potential future capital. The options are exercisable at $0.02 each before September 2028, with no immediate funds raised from the issue.

Critica Limited has raised A$8 million in an oversubscribed placement to accelerate development of its Jupiter rare earths project, positioning itself as a key supplier of critical minerals for emerging technologies.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Volt Group Limited has locked in a conditional $4 million placement to support its acquisition of 4D Delta, backed by strong institutional and director participation. The raise, priced at a discount to recent trading, aims to accelerate growth initiatives and strengthen working capital.

Catapult Sports has successfully closed its Share Purchase Plan, raising A$13.3 million as part of a broader A$143.3 million equity raising to support strategic expansion and acquisitions.

Barton Gold Holdings has bolstered its cash reserves to an estimated $20 million following a successful $15 million institutional placement and a $660,000 Share Purchase Plan, positioning the company to advance key gold development projects in South Australia.

Terrain Minerals has successfully raised $1.32 million through a share placement to fund exploration at its Smokebush Project, targeting high-grade gold and silver deposits.

Clean TeQ Water has raised A$6 million through a placement supported by major shareholders to fund its expanding international water and resource recovery projects while strengthening its balance sheet.

Encounter Resources has completed the first tranche of its $25 million share placement, raising approximately $24.5 million to advance its mineral exploration projects. The second tranche, involving shares to a company director, awaits shareholder approval.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.